Home › Funds › ADAR1 Capital Management, LLC › ANL
ADAR1 Capital Management, LLC position in ANL
ADLAI NORTYE GROUP LTD · Health Care
ADAR1 Capital Management, LLC reported holding 1,017,805 shares of ANL (ADLAI NORTYE GROUP LTD) in its Q2 2026 13F filing — a position valued at US$11.7M, representing 0.65% of its reported portfolio and ranking #44 among its reported holdings. ADAR1 Capital Management, LLC has disclosed ANL holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ADAR1 Capital Management, LLC's ANL position evolved
ADAR1 Capital Management, LLC first disclosed a stake in ANL in Q1 2026 at 117,909 shares (US$816K). The position peaked in Q2 2026 at 1,017,805 shares, worth US$11.7M. Across 2 filings, ADAR1 Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,017,805 shares valued at US$11.7M — an increase of 899,896 shares quarter over quarter.. Notable position changes include a 763% increase in Q2 2026 (shares rose 39% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 117.91K | $815.93K | New |
| Q2 2026 | 1.02M | $11.70M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANL and 13F data
ANL (ADLAI NORTYE GROUP LTD) is a Health Care company. 41 other funds we track also report a position in ANL — the largest reported positions include Cormorant Asset Management, LP (US$45.7M), Venrock Adviser, LLC (US$36.9M), MPM BioImpact LLC (US$22.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANL
- Cormorant Asset Management, LP 3.98M sh · $45.75M · Q2 2026
- Venrock Adviser, LLC 3.21M sh · $36.95M · Q2 2026
- MPM BioImpact LLC 1.94M sh · $22.27M · Q2 2026
- Casdin Capital 1.25M sh · $14.38M · Q2 2026
- Octagon Capital Advisors LP 934.72K sh · $10.75M · Q2 2026
- Squadron Capital Management LLC 764.88K sh · $8.80M · Q2 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 552.50K sh · $6.35M · Q2 2026
- BOONE CAPITAL MANAGEMENT LLC 258.39K sh · $2.97M · Q2 2026
- DAFNA Capital Management LLC 239.55K sh · $2.75M · Q2 2026
- Kalehua Capital Management LLC 226.41K sh · $2.60M · Q2 2026
- ACT CAPITAL MANAGEMENT, LLC 27.00K sh · $310.50K · Q2 2026
More on ADAR1 Capital Management, LLC
FAQ
How long has ADAR1 Capital Management, LLC held ANL?
ADAR1 Capital Management, LLC has disclosed ANL holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is ADAR1 Capital Management, LLC's current position in ANL?
As of Q2 2026, ADAR1 Capital Management, LLC holds 1.02M shares of ANL (ADLAI NORTYE GROUP LTD), valued at $11.70M, representing 0.65% of its reported portfolio and ranking #44.
Has ADAR1 Capital Management, LLC been buying or selling ANL?
In the latest 13F filing (Q2 2026), ADAR1 Capital Management, LLC increased its position in ANL. The position peaked in Q2 2026 at 1.02M shares.
Which other funds hold ANL?
Other major institutional holders of ANL include Cormorant Asset Management, LP, Venrock Adviser, LLC, MPM BioImpact LLC, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.